Companies also enter a separate regional rights agreement granting BeOne exclusive development and c

SAN CARLOS, Calif. & REDWOOD CITY, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Na

Dimensional Fund Advisors LP increased its stake in BeOne Medicines Ltd. - Sponsored ADR (NASDAQ: ON

TD Cowen analyst Yaron Werber maintains BeOne Medicines (NASDAQ:ONC) with a Buy and raises the pr

RBC Capital analyst Leonid Timashev maintains BeOne Medicines (NASDAQ:ONC) with a Outperform and

Truist Securities analyst Gregory Renza maintains BeOne Medicines (NASDAQ:ONC) with a Buy and rai

Guggenheim analyst Michael Schmitz maintains BeOne Medicines (NASDAQ:ONC) with a Buy and raises t

Citizens analyst Reni J. Benjamin maintains BeOne Medicines (NASDAQ:ONC) with a Market Outperform

BeOne Medicines NASDAQ: ONC reported second-quarter revenue of $1.7 billion, up 30% from a year earl

BeOne Medicines AG (ONC) Q2 2026 Earnings Call Transcript

While the top- and bottom-line numbers for BeOne Medicines Ltd. - Sponsored ADR (ONC) give a sense o

BeOne Medicines (NASDAQ:ONC) raises FY2026 sales outlook from $6.300 billion-$6.500 billion to $6.60

BeiGene (NASDAQ:ONC) reported quarterly earnings of $3.84 per share which beat the analyst consensus

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. announced financial result

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for BeOne Medicines Ltd. - Spons

Arrowstreet Capital Limited Partnership grew its stake in BeOne Medicines Ltd. - Sponsored ADR (NASD

JP Morgan analyst Jessica Fye maintains BeOne Medicines (NASDAQ:ONC) with a Overweight and raises

FBT surged 51.6% in one year but carries higher risk and costs. VHT offers broader diversification a

The expansion will increase BeOne's production capacity to manufacture its medicines and is expe

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines, Ltd. announced a $300 million

Executed under pre-established trading plan, this sale reduces the chief executive's direct holdings

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160;

Barclays analyst Peter Lawson maintains BeOne Medicines (NASDAQ:ONC) with a Overweight and lowers

Jefferies analyst Faisal Khurshid upgrades BeOne Medicines (NASDAQ:ONC) from Hold to Buy and rais

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160;

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160;

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160;

BeOne Medicines AG (ONC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Tra

BeOne Medicines Ltd. - Sponsored ADR (ONC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflec

BeOne Medicines AG (ONC) Discusses Solid Tumor Portfolio Progress and R&D Pipeline Strategy at ASCO

BeOne Medicines NASDAQ: ONC used an investor event at ASCO to outline what executives described as a

Summit Therapeutics' shares rose as much as 7% before the bell after its ivonescimab therapy with Ch

Jazz Pharmaceuticals reported Phase 3 trial results showing Ziihera helped patients with advanced HE

Nutanix, Burlington Stores, Oracle and other major names led last week's steepest large-cap stoc

Zymeworks rises after Ziihera shows significant PFS and OS benefits in a Phase 3 trial, supporting p

Ziihera plus chemotherapy showed a clinically meaningful and statistically significant improvement i

BeOne Medicines will sell global Imdelltra royalties to Royalty Pharma for up to $950 million while

Under the terms of the agreement, BeOne will receive an upfront payment of $885 million, with the op